These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 1989250)

  • 1. Reversible vanishing bile duct syndrome after liver transplantation: report of 6 cases.
    Hubscher SG; Buckels JA; Elias E; McMaster P; Neuberger JM
    Transplant Proc; 1991 Feb; 23(1 Pt 2):1415-6. PubMed ID: 1989250
    [No Abstract]   [Full Text] [Related]  

  • 2. Combination immunosuppression with azathioprine reduces the incidence of ductopenic rejection and vanishing bile duct syndrome after liver transplantation.
    van Hoek B; Wiesner RH; Ludwig J; Gores GJ; Moore B; Krom RA
    Transplant Proc; 1991 Feb; 23(1 Pt 2):1403-5. PubMed ID: 1989248
    [No Abstract]   [Full Text] [Related]  

  • 3. Severe ductopenic rejection with features of vanishing bile duct syndrome: clinical, biochemical, and histologic evidence for spontaneous resolution.
    Noack KB; Wiesner RH; Batts K; van Hoek B; Ludwig J
    Transplant Proc; 1991 Feb; 23(1 Pt 2):1448-51. PubMed ID: 1989260
    [No Abstract]   [Full Text] [Related]  

  • 4. Recurrence of ductopenic rejection in liver allografts after retransplantation for vanishing bile duct syndrome.
    van Hoek B; Wiesner RH; Ludwig J; Paya C
    Transplant Proc; 1991 Feb; 23(1 Pt 2):1442-3. PubMed ID: 1703343
    [No Abstract]   [Full Text] [Related]  

  • 5. The acute vanishing bile duct syndrome (acute irreversible rejection) after orthotopic liver transplantation.
    Ludwig J; Wiesner RH; Batts KP; Perkins JD; Krom RA
    Hepatology; 1987; 7(3):476-83. PubMed ID: 3552923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vanishing bile-duct syndrome following liver transplantation--is it reversible?
    Hubscher SG; Buckels JA; Elias E; McMaster P; Neuberger J
    Transplantation; 1991 May; 51(5):1004-10. PubMed ID: 1851580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic liver transplant rejection: definition and diagnosis.
    Wight DA
    Transplant Proc; 1996 Feb; 28(1):465-7. PubMed ID: 8644314
    [No Abstract]   [Full Text] [Related]  

  • 8. [Vanishing bile duct syndrome].
    Hashimoto E; Hayashi N
    Ryoikibetsu Shokogun Shirizu; 1995; (7):574-6. PubMed ID: 8749558
    [No Abstract]   [Full Text] [Related]  

  • 9. Portal capillary destruction in liver allograft rejection.
    Matsumoto Y; McCaughan GW; Bishop GA
    Transplant Proc; 1992 Feb; 24(1):196-7. PubMed ID: 1539242
    [No Abstract]   [Full Text] [Related]  

  • 10. Is exfoliative bile cytology useful in the diagnosis of graft complications in liver transplantation?
    Carrasco L; Sánchez-Bueno F; Sola J; Acosta F; Ramirez P; Robles R; Flores B; Parrilla P
    Transplant Proc; 1995 Aug; 27(4):2281-2. PubMed ID: 7652806
    [No Abstract]   [Full Text] [Related]  

  • 11. Early cellular rejection treated with high-dose intravenous corticosteroid therapy is associated with a decrease in the incidence of steroid-resistant rejection and graft failure from rejection.
    Wiesner RH; Porayko MK; Wahlstrom HE; Gores GJ; Kamath PS; Hay JE; Krom RA
    Transplant Proc; 1993 Apr; 25(2):1791-3. PubMed ID: 7682352
    [No Abstract]   [Full Text] [Related]  

  • 12. Diagnosis of rejection in liver transplantation.
    Höckerstedt K; Lautenschlager I; Scheinin TM; Ahonen J; Eklund B; Häyry P; Korsbäck C; Maury P; Salmela K; Taskinen E
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2483-4. PubMed ID: 3274542
    [No Abstract]   [Full Text] [Related]  

  • 13. Transplantation aspiration cytology in the diagnosis of steroid resistant rejection in liver allograft patients.
    Nashan B; Schlitt HJ; Ringe B; Bunzendahl H; Wonigeit K; Pichlmayr R
    Transplant Proc; 1990 Oct; 22(5):2297-8. PubMed ID: 2219376
    [No Abstract]   [Full Text] [Related]  

  • 14. Histologic and biochemical changes during the evolution of chronic rejection of liver allografts.
    Neil DA; Hubscher SG
    Hepatology; 2002 Mar; 35(3):639-51. PubMed ID: 11870379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence and patterns of rejection using different induction therapies in liver transplant recipients.
    Elkashab M; Reizig M; Greig PD; Cameron R; Phillips MJ; Chung S; Cattral M; Levy G
    Transplant Proc; 1994 Oct; 26(5):2669-71. PubMed ID: 7940835
    [No Abstract]   [Full Text] [Related]  

  • 16. Diagnosis and grading of liver allograft rejection: a European perspective.
    Hübscher S
    Transplant Proc; 1996 Feb; 28(1):504-7. PubMed ID: 8644330
    [No Abstract]   [Full Text] [Related]  

  • 17. Histologic changes resembling acute rejection in a liver transplant patient treated with terbinafine.
    Lovell MO; Speeg KV; Havranek RD; Sharkey FE
    Hum Pathol; 2003 Feb; 34(2):187-9. PubMed ID: 12612888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytomegalovirus infection is associated with increased inflammation and severe bile duct damage in rat liver allografts.
    Martelius T; Krogerus L; Höckerstedt K; Bruggeman C; Lautenschlager I
    Hepatology; 1998 Apr; 27(4):996-1002. PubMed ID: 9537439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased bile duct complications in ABO incompatible liver transplant recipients.
    Sanchez-Urdazpal L; Sterioff S; Janes C; Schwerman L; Rosen C; Krom RA
    Transplant Proc; 1991 Feb; 23(1 Pt 2):1440-1. PubMed ID: 1989259
    [No Abstract]   [Full Text] [Related]  

  • 20. Use of triple therapy and percutaneous needle biopsy to minimize graft failure following liver transplantation.
    St Cyr JA; Elick B; Freese D; Sharp H; Payne W; Bloomer J; Stock P; Snover D; Najarian JS; Ascher NL
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2451-3. PubMed ID: 3274535
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.